Lord, Abbett & Co’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.5M Buy
452,077
+359,530
+388% +$19.5M 0.11% 216
2026
Q1
$3.57M Sell
92,547
-607,743
-87% -$25.3M 0.01% 497
2025
Q4
$32.5M Buy
700,290
+51,198
+8% +$2.47M 0.1% 203
2025
Q3
$31.9M Buy
649,092
+133,627
+26% +$6.99M 0.09% 228
2025
Q2
$26.7M Buy
+515,465
New +$20.8M 0.09% 241

Other funds holding HNGE

Lord, Abbett & Co's HNGE Position: Q2 2026 in Review

Lord, Abbett & Co increased its Hinge Health (HNGE) stake by 388% in Q2 2026, buying an estimated $19.5M and bringing the position to 452,077 shares worth $37.5M. The position accounts for 0.11% of the portfolio, ranked #216.

Lord, Abbett & Co first reported a position in HNGE in Q2 2025 and has held it in 5 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

  • Lord, Abbett & Co held 452,077 shares of Hinge Health worth $37.5M as of Q2 2026.
  • Lord, Abbett & Co bought 359,530 Hinge Health shares in Q2 2026, an estimated $19.5M.
  • Hinge Health made up 0.11% of Lord, Abbett & Co's portfolio in Q2 2026, its #216 holding.
  • Lord, Abbett & Co first reported a position in Hinge Health in Q2 2025 and has held it in 5 quarters since.
  • 277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.